VNDA Past Earnings image   This VNDA past earnings page last updated 8/5/2022
VNDA Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/3/20220.050
Q1 20225/5/2022-0.110
Q4 20212/23/20220.120
Q3 202111/3/20210.140
Q2 20217/28/20210.170
Q1 20215/5/20210.150
Q4 20202/10/20210.150
Q3 202010/28/20200.110
Q2 20208/5/20200.160
Q1 20205/6/20200.010
Q4 20192/25/20200.080
Q3 201911/6/20190.230
Q2 20197/31/20190.280
Q1 20195/1/20190.060
Q4 20182/13/20190.26
Q3 201811/7/20180.2
Q2 20188/1/20180.14
Q1 20185/2/20180.14
Q4 20172/14/20180.03
Q3 201711/7/2017-0.03
Q2 20178/2/20170.03
Q1 20175/2/2017-0.11
Q4 20162/15/20170.08
Q3 201611/2/2016-0.01
Q2 20167/27/20160.01
Q1 20165/4/2016-0.17
Q4 20152/10/2016-0.23
Q3 201511/3/2015-0.22
Q2 20157/29/2015-0.01
Q1 20155/6/2015-0.24
Q4 20142/19/2015-0.36
Q3 201410/27/2014-0.04
Q2 20148/7/2014-0.64
Q1 20145/8/2014-0.79
Q4 20132/13/2014-0.23
Q3 201311/7/2013-0.17
Q2 20137/31/2013-0.11
Q1 20135/9/2013-0.15
Q4 20122/12/2013-0.23
Q3 201211/7/2012-0.19
Q2 20128/2/2012-0.28
VNDA Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/3/20220.06B
Q1 20225/5/20220.06B
Q4 20212/23/20220.07B
Q3 202111/3/20210.07B
Q2 20217/28/20210.07B
Q1 20215/5/20210.06B
Q4 20202/10/20210.07B
Q3 202010/28/20200.06B
Q2 20208/5/20200.06B
Q1 20205/6/20200.06B
Q4 20192/25/20200.06B
Q3 201911/6/20190.06B
Q2 20197/31/20190.06B
Q1 20195/1/20190.05B
Q4 20182/13/201953.04M
Q3 201811/7/201849.13M
Q2 20188/1/201847.35M
Q1 20185/2/201843.59M
Q4 20172/14/201844.28M
Q3 201711/7/201741.34M
Q2 20178/2/201742.06M
Q1 20175/2/201737.41M
Q4 20162/15/201738.24M
Q3 201611/2/201638.48M
Q2 20167/27/201636.03M
Q1 20165/4/201633.26M
Q4 20152/10/201631.85M
Q3 201511/3/201528.34M
Q2 20157/29/201527.58M
Q1 20155/6/201522.15M
Q4 20142/19/201515.37M
Q3 201410/27/201414.80M
Q2 20148/7/201410.90M
Q1 20145/8/20149.14M
Q4 20132/13/20148.78M
Q3 201311/7/20138.71M
Q2 20137/31/20138.30M
Q1 20135/9/20138.07M
Q4 20122/12/20137.90M
Q3 201211/7/20128.29M
Q2 20128/2/20120.01B
Quotes delayed 20 minutes

Email EnvelopeFree VNDA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Vanda Pharmaceuticals (VNDA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VOR Past Earnings
VRAY Past Earnings
VRCA Past Earnings
VRDN Past Earnings
VRPX Past Earnings
VRTX Past Earnings
VSTM Past Earnings
VTGN Past Earnings
VTRS Past Earnings
VTVT Past Earnings

VNDA Past Earnings Q&A

What was the best and worst VNDA past earnings results?
For Vanda Pharmaceuticals, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest VNDA past earnings result in our data set was 0.280/share posted in Q2 2019, while the lowest was in Q1 2014 when VNDA posted -0.79/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2021 when VNDA reported 0.07B in revenue, while the quarter with the lowest revenue in our data set was Q4 2012 at 7.90M of revenue.

  Suggested answer: There are 41 VNDA past earnings results in our data set.

On this page we presented the VNDA past earnings date information for Vanda Pharmaceuticals. Reviewing that VNDA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2019, when VNDA posted gaap of 0.280/share. Meanwhile the lowest VNDA past earnings result was in Q1 2014, when VNDA posted gaap of -0.79/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2021 when VNDA reported 0.07B in revenue, while the smallest revenue quarter was Q4 2012 when VNDA reported 7.90M in revenue.

Any self directed investor doing their due diligence on VNDA or any other given stock can benefit from researching all of the Vanda Pharmaceuticals past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Vanda Pharmaceuticals past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VNDA. Thanks for visiting, and the next time you need to research VNDA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of SQZ, SHOO Split History, Top Ten Hedge Funds Holding AC.

 

VNDA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.